-
1
-
-
33644522035
-
Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: A 12 week, open-label, extension study
-
Thase ME, Fava M, Debattista C et al. Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: a 12 week, open-label, extension study. CNS Spectrums 2006 11 : 93 102.
-
(2006)
CNS Spectrums
, vol.11
, pp. 93-102
-
-
Thase, M.E.1
Fava, M.2
Debattista, C.3
-
2
-
-
34548102009
-
A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression
-
Frye MA, Grunze H, Suppes T et al. A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression. Am J Psychiatry 2007 164 : 1242 1249.
-
(2007)
Am J Psychiatry
, vol.164
, pp. 1242-1249
-
-
Frye, M.A.1
Grunze, H.2
Suppes, T.3
-
3
-
-
33947272977
-
Psychostimulants in the treatment of depression. A Review of the Evidence. Review Article
-
Orr K, Taylor D. Psychostimulants in the treatment of depression. A Review of the Evidence. Review Article. CNS Drugs 2007 21 : 239 257.
-
(2007)
CNS Drugs
, vol.21
, pp. 239-257
-
-
Orr, K.1
Taylor, D.2
-
5
-
-
0021945989
-
Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression
-
Feighner JP, Herbstein J, Damlouji N. Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression. J Clin Psychiatry 1985 46 : 206 209.
-
(1985)
J Clin Psychiatry
, vol.46
, pp. 206-209
-
-
Feighner, J.P.1
Herbstein, J.2
Damlouji, N.3
-
6
-
-
0025860023
-
CNS stimulant potentiation of monoamine oxidase inhibitors in treatment-refractory depression
-
Fawcett J, Kravitz HM, Zajecka JM et al. CNS stimulant potentiation of monoamine oxidase inhibitors in treatment-refractory depression. J Clin Psychopharm 1991 11 : 127 132.
-
(1991)
J Clin Psychopharm
, vol.11
, pp. 127-132
-
-
Fawcett, J.1
Kravitz, H.M.2
Zajecka, J.M.3
-
7
-
-
0030022134
-
Methylphenidate augmentation of serotonin selective reuptake inhibitors: A case series
-
Stoll AL, Pillay SS, Diamond L et al. Methylphenidate augmentation of serotonin selective reuptake inhibitors: a case series. J Clin Psychiatry 1996 57 : 72 76.
-
(1996)
J Clin Psychiatry
, vol.57
, pp. 72-76
-
-
Stoll, A.L.1
Pillay, S.S.2
Diamond, L.3
-
8
-
-
0026167906
-
Combination of fluoxetine with pemoline in the treatment of major depressive disorder
-
Metz A, Shader RI. Combination of fluoxetine with pemoline in the treatment of major depressive disorder. Int Clin Psychopharmacol 1991 6 : 93 96.
-
(1991)
Int Clin Psychopharmacol
, vol.6
, pp. 93-96
-
-
Metz, A.1
Shader, R.I.2
-
9
-
-
33751112745
-
A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression
-
Patkar AA, Masand PS, Pae CU et al. A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression. J Clin Psychopharmacol 2006 26 : 653 656.
-
(2006)
J Clin Psychopharmacol
, vol.26
, pp. 653-656
-
-
Patkar, A.A.1
Masand, P.S.2
Pae, C.U.3
-
10
-
-
39549119969
-
Osmotic-release oral system methylphenidate augmentation of antidepressant monotherapy in major depressive disorder: Results of a double-blind, randomized, placebo-controlled trial
-
Ravindran AV, Kennedy SH, O'Donovan MC et al. Osmotic-release oral system methylphenidate augmentation of antidepressant monotherapy in major depressive disorder: results of a double-blind, randomized, placebo-controlled trial. J Clin Psychiatry 2008 69 : 87 94.
-
(2008)
J Clin Psychiatry
, vol.69
, pp. 87-94
-
-
Ravindran, A.V.1
Kennedy, S.H.2
O'Donovan, M.C.3
-
12
-
-
0031893206
-
Modafinil: A review of its pharmacology and clinical efficiency in the management of narcolepsy
-
Mcclelland KJ, Spencer CM. Modafinil: a review of its pharmacology and clinical efficiency in the management of narcolepsy. CNS Drugs 1998 9 : 311 324.
-
(1998)
CNS Drugs
, vol.9
, pp. 311-324
-
-
McClelland, K.J.1
Spencer, C.M.2
-
13
-
-
0035864193
-
Therapeutic doses of methylphenidate significantly increase extracellular dopamine in the human brain
-
Volkow ND, Wang G, Fowler JS et al. Therapeutic doses of methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci 2001 21 : RC121.
-
(2001)
J Neurosci
, vol.21
, pp. 121
-
-
Volkow, N.D.1
Wang, G.2
Fowler, J.S.3
-
14
-
-
34548030683
-
Differential effects of adjunctive methylphenidate and citalopram on extracellular levels of serotonin, noradrenaline and dopamine in the rat brain
-
Weikop P, Yoshitake T, Kehr J. Differential effects of adjunctive methylphenidate and citalopram on extracellular levels of serotonin, noradrenaline and dopamine in the rat brain. Eur Neuropsychopharmacology, 2007 17 : 658 671.
-
(2007)
Eur Neuropsychopharmacology
, vol.17
, pp. 658-671
-
-
Weikop, P.1
Yoshitake, T.2
Kehr, J.3
-
15
-
-
77949746084
-
-
MiMS Annual, 28th edn. MIMS Australia. Sydney
-
MiMS Annual, 28th edn. MIMS Australia, Sydney 2004.
-
(2004)
-
-
-
16
-
-
0034758620
-
Pharmacokinetic and pharmacodynamic drug interactions in treatment of attention-deficit hyperactivity disorder
-
Markowitz JS, Patrick KS. Pharmacokinetic and pharmacodynamic drug interactions in treatment of attention-deficit hyperactivity disorder. Clin Pharmacokinet 2001 40 : 753 772.
-
(2001)
Clin Pharmacokinet
, vol.40
, pp. 753-772
-
-
Markowitz, J.S.1
Patrick, K.S.2
-
17
-
-
0002479620
-
Treatment-resistant depression
-
In. Bloom, F.E. Kupfer, D.J. eds. New York, NY. Raven Press
-
Thase ME, Rush AJ. Treatment-resistant depression. In : Bloom FE, Kupfer DJ, eds. Psychopharmacology: the fourth generation of progress. New York, NY : Raven Press, 1995 : 1081 1097.
-
(1995)
Psychopharmacology: The Fourth Generation of Progress.
, pp. 1081-1097
-
-
Thase, M.E.1
Rush, A.J.2
|